Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment
- PMID: 2053170
Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment
Similar articles
-
Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.Czech Med. 1990;13(2-3):98-106. Czech Med. 1990. PMID: 2245762
-
[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].Rev Med Chil. 1990 Jun;118(6):629-34. Rev Med Chil. 1990. PMID: 1775783 Spanish.
-
[Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].Sangre (Barc). 1990 Feb;35(1):82-4. Sangre (Barc). 1990. PMID: 2333585 Spanish.
-
Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.Clin Nephrol. 1997 Jul;48(1):1-8. Clin Nephrol. 1997. PMID: 9247771 Review.
-
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.Transplant Proc. 1991 Apr;23(2):1831-2. Transplant Proc. 1991. PMID: 2053169 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical